Corcept Therapeutics Incorporated · NASDAQ:CORT

Vieira Roberto Wandenkolk sold 58,333 Corcept Therapeutics Incorporated shares (Form 4)

Traded Sep 1 to Sep 2, 2026 · Filed Sep 3, 2026

From Sep 1 to Sep 2, 2026, Vieira Roberto Wandenkolk (President, Oncology) sold 58,333 Corcept Therapeutics Incorporated shares at an average US$110.76 for US$6.46M under a trading plan, leaving 4,242 shares. Filed Sep 3, 2026 (Form 4).

Sold
58,333 shares
Price
US$110.76 average (US$109.35 to US$115.44)
Value
US$6.46M
Holding after
4,242 shares
Trading plan
Yes (Made under a plan set in advance)
Role
President, Oncology

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 1, 2026Common StockAward138US$113.384,206Direct
Sep 1, 2026Common StockAward1384,344Direct
Sep 2, 2026Common StockShares withheld for tax102US$113.384,242Direct
Sep 2, 2026Common StockOption exercise58,333US$21.6362,575Direct
Sep 2, 2026Common StockSale23,600US$109.3538,975Direct
Sep 2, 2026Common StockSale23,770US$110.7015,205Direct
Sep 2, 2026Common StockSale1,537US$111.3713,668Direct
Sep 2, 2026Common StockSale974US$112.4012,694Direct
Sep 2, 2026Common StockSale1,606US$113.7211,088Direct
Sep 2, 2026Common StockSale5,621US$114.585,467Direct
Sep 2, 2026Common StockSale1,225US$115.444,242Direct

Source

View original at SEC

Related